Background: Misoprostol has been extensively used in obstetrics and has proved to be a very effective cervical softening agent before termination of pregnancy. The beneficial effects on cervical ripening may make misoprostol a desirable agent for helping cervical dilatation on non pregnant women. Aim: To compare the efficacy and safety of pre-procedure sublingual misoprostol versus pervaginal misoprostol for relief of pain during and after the HSG procedure. Materials and methods: Study was initiated after approval from the IEC. There after subject recruitment had done form July 2017 to June 2018 in the department of Obstetrics & Gynaecology (indoor setting) of IPGME&R & SSKM Hospital Result: We found that association of cervical resistance score vas vs. group was statistically significant (p<0.0001). Association of need for analgesics vs. group was not statistically significant (p=0.11004). Association of any adverse effect vs. group was not statistically significant (p=1.0000). Difference of mean age vs. group was not statistically significant (p=0.0717). Conclusion: There was no significant difference of pain after the HSG procedure in both the group. The patients who were received sublingual misoprostol had significantly low cervical resistance during the procedure.

INTRODUCTION Contraception is one of the proximate determinants of fertility and the most important predictor of fertility transition. Contraceptive use helps couples and individuals realize their basic right to decide freely and responsibly if, when and how many children to have. The growing use of contraceptive methods has resulted in not only improvements in health-related outcomes such as reduced maternal mortality and infant mortality, but also improvements in schooling and economic outcomes, especially for girls and women. AIMS & OBJECTIVES Find out the proportion of accepting the Post-Partum Intrauterine Contraceptive Device (PPIUCD) insertion among eligible women delivering at SSKM hospital. The complications of post placental &intra caesarean PPIUCD if any among these acceptors. Determine the spontaneous expulsion rate of this contraceptive device. MATERIALS AND METHODS Descriptive study with a longitudinal design. The present study was a hospital based study conducted at the department of Gynecology and Obstetrics department of the Institute of Post graduate Medical Education and Research (IPGMER) and SSKM. The study was conducted for a period of 18 months between April 2017 To September 2018. All 243 pregnant eligible women who delivered either by normal vaginal or instrumental delivery or caesarean section during the data collection period. RESULTS The above table shows that most of the participants enrolled in the study were in the age group of 21 - 25 years (39.9%), had completed secondary education (32.0%) and were housewives (74.2%), of urban residence (63.5%). About half of the participants were Muslim (49.4%), 47.2% were Hindus while 3.4% were Christians. SUMMARY AND CONCLUSIONS It can be concluded that PPIUCD is a promising new approach. Cu T 380A inserted in the post-partum period is both convenient and safe. The advantage of single visit insertion can be utilised to expand the usage of IUCD to meet the unmet needs of contraception.